Tempus AI · 3 hours ago
Senior Epidemiologist
New York, NY
Full-time
Hybrid
Senior Level
$100K/yr - $160K/yr
5+ years expTempus AI is focused on advancing the healthcare industry through precision medicine and AI technology. They are seeking a highly motivated and capable epidemiologist to join their Outcomes Research team, responsible for designing and analyzing pharmacoepidemiological studies and collaborating with various teams to enhance data quality.
Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningMedicalPrecision Medicine
Responsibilities
Contribute to the design and execution of RWE studies by developing protocols, crafting statistical analysis plans, and creating analysis deliverables such as table shells, leveraging Tempus’s data to support external Pharma Medical Affairs, HEOR, and RWE team objectives. Lead independent analysis of Tempus data for Pharma RWE studies, involving extensive coding, comprehension of Tempus molecular and clinical data, acquisition of oncology-specific clinical insights, derivation of real-world endpoints using time-to-event methodology, and staying abreast of current NCCN guidelines and the evolving oncology landscape within a retrospective database
Present insights from RWE studies to external Pharma epidemiologists and medical liaisons through formal presentations, providing strategic recommendations. Communicate research findings effectively, interpreting results and drawing appropriate inferences based on study design/statistical methods, while also evaluating study limitations
Collaborate with internal product, engineering, oncology, bioinformatics, and clinical abstraction teams to continually enhance Tempus data quality and feature builds for retrospective analysis. Work with translational research and computational biologists to analyze Tempus sequencing data within RWE studies
Stay updated on methodological advancements in real-world studies, oncology guidelines, and ongoing clinical trials. Demonstrate proficiency in various types of RWD and their suitability for analysis, distinguishing between retrospective RWD, clinical trials, and other prospective observational study designs, and articulating their advantages and limitations
Ensure compliance with all relevant regulations and company procedures
Qualification
Required
Masters or Phd Degree in epidemiology, biostatistics, health economics or a related discipline and 5+ years of post-grad experience
Experience in conducting observational retrospective analyses in oncology including a published track record
Computational skills using R and SQL, especially relevant statistical tools and packages
Preferred
Prior involvement in oncology Phase II-IV clinical trials or proven expertise in analyzing RWD studies, including utilization of claims, EHR, or registry data
Demonstrated experience interfacing with clients or in a consulting capacity, showcasing adeptness in presenting results to stakeholders
Proficiency in navigating large, complex problems within a fast-paced environment
Meticulous attention to detail coupled with a commitment to delivering analytics of the highest quality and punctuality
A collaborative mindset, coupled with a genuine eagerness to learn and a steadfast dedication to maintaining integrity in all endeavors
Direct involvement in assisting with the preparation of regulatory submissions to the FDA or EMA
Proficiency in machine learning techniques, with a nuanced understanding of the strengths and limitations of various approaches, particularly regarding predictive and prognostic algorithms in medical research
Familiarity with cancer genetics, immunology, or molecular biology
Benefits
Incentive compensation
Restricted stock units
Medical and other benefits depending on the position
Company
Tempus AI
Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data.
1001-5000 employees
H1B Sponsorship
Tempus AI has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2021 (3)
Funding
Current Stage
Public CompanyTotal Funding
$2.29BKey Investors
Ares ManagementGoogleBaillie Gifford
2025-06-30Post Ipo Debt· $650M
2025-02-19Post Ipo Debt· $300M
2024-06-14IPO
Leadership Team
Eric Lefkofsky
Founder and CEO
Shane Colley
CTO
Recent News
Company data provided by crunchbase